India weighing Russian offer for Sputnik-V vaccine trial, manufacturing - official
"The government of India attaches great importance to this offer of partnership from a friend," said VK Paul, member of the Indian federal government think-tank NITI Aayog
A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS
India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" Covid-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said on Tuesday.
"The government of India attaches great importance to this offer of partnership from a friend," said VK Paul, member of the Indian federal government think-tank NITI Aayog.
The outcome of discussions on the offer were expected soon, he added.
Keep updated, follow The Business Standard's Google news channel
